Zevra Therapeutics, Inc. ZVRA Operating Lease Right-of-Use Assets in Other Assets
Operating Lease Right-of-Use Assets in Other Assets at other companies
Other financials
Where this comes from
Reported directly by Zevra Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Zevra Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Zevra Therapeutics, Inc.'s operating lease right-of-use assets in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Zevra Therapeutics, Inc.'s operating lease right-of-use assets in other assets?
- Zevra Therapeutics, Inc. (ZVRA) reported operating lease right-of-use assets in other assets of $1.09M in Q1 2026.
- How has Zevra Therapeutics, Inc.'s operating lease right-of-use assets in other assets changed year-over-year?
- Zevra Therapeutics, Inc.'s operating lease right-of-use assets in other assets decreased by 33.6% year-over-year, from $1.64M to $1.09M.
- What is the long-term trend for Zevra Therapeutics, Inc.'s operating lease right-of-use assets in other assets?
- Over 5 years (2020 to 2025), Zevra Therapeutics, Inc.'s operating lease right-of-use assets in other assets has grown at a -2.1% compound annual growth rate (CAGR), from $1.35M to $1.21M.